Raltegravir central nervous system tolerability in clinical practice

Population Pharmacokinetic Analysis and Pharmacogenetics of Raltegravir in HIV-Positive and Healthy Individuals

(2012) Mona Arab-Alameddine et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Severe insomnia related to high concentrations of raltegravir

(2011) Céline Eiden et al.   AIDS

Successful efavirenz dose reduction guided by therapeutic drug monitoring

(2011) Aurélie Fayet Mello et al.   ANTIVIRAL THERAPY

Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects

(2011) D. Cattaneo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Raltegravir penetration in the cerebrospinal fluid of HIV-positive patients

(2010) Andrea Calcagno et al.   AIDS

Long‐Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment‐Experienced Patients with Drug‐Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials

(2010) Roy T. Steigbigel et al.   CLINICAL INFECTIOUS DISEASES

Long-Term Efficacy and Safety of the HIV Integrase Inhibitor Raltegravir in Patients With Limited Treatment Options in a Phase II Study

(2010) Jose M Gatell et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Acute Onset Insomnia Associated with the Initiation of Raltegravir: A Report of Two Cases and Literature Review

(2009) Jacob Gray et al.   AIDS PATIENT CARE AND STDS

Effects of Omeprazole on Plasma Levels of Raltegravir

(2009) Marian Iwamoto et al.   CLINICAL INFECTIOUS DISEASES

Sustained Antiretroviral Effect of Raltegravir After 96 Weeks of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection

(2009) Martin Markowitz et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

(2009) Jeffrey L Lennox et al.   LANCET

Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection

(2009) Aylin Yilmaz et al.   PLoS One

Exacerbation of depression associated with starting raltegravir: a report of four cases

(2008) Marianne Harris et al.   AIDS

Lack of a Significant Drug Interaction between Raltegravir and Tenofovir

(2008) L. A. Wenning et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Raltegravir: The first HIV integrase inhibitor

(2008) Jennifer Cocohoba et al.   CLINICAL THERAPEUTICS